
February 1, 2023
BRC Newsletter – February 2023
Click here to read the February 2023 Newsletter

February 1, 2023
Click here to read the February 2023 Newsletter

January 31, 2023
Antoniak Lab published a study investigating the role of thrombin-PAR1 signaling in chemotherapy induced heart failure. UNC Blood Research Center researchers Drs Grover, Bharathi, Mackman and Antoniak in collaboration with Drs. Posma, Griffin and Palumbo published in Blood Advances “Thrombin mediated activation of PAR1 enhances doxorubicin induced cardiac injury in mice”. Dr. Antoniak was the …
January 31, 2023
The contact pathway of coagulation has been implicated in the pathogenesis of venous thrombosis. Relatively little, however, is known about the the role of C1 inhibitor, the major negative regulator of this pathway, in venous thrombosis. Work led by Steven Grover and Nigel Mackman revealed that C1 inhibitor deficiency, resulting in the genetic disorder Hereditary …

January 31, 2023
Work led by postdoctoral fellow Jun Wan, PhD under the supervision of Steven Grover, PhD and Nigel Mackman, PhD establishing a novel mouse whole blood thrombin generation assay has been published in the Journal Blood Advances. In this work the authors found that the novel mouse whole blood assay provided increased sensitivity to amplifying coagulation …
January 31, 2023
Congratulations to Research Assistant Professor Steven Grover, PhD who received a 2023 UNC Junior Faculty Development Award to support his work studying “The role of endogenous C1 inhibitor as a negative regulator of coagulation in the general population”. This highly competitive award is supported by the UNC Office of the Provost with funds provided by IBM and R.J. …

January 31, 2023
Rafal Pawlinski, PhD and Jian Liu, PhD were published in the Proceedings of the National Academy of Sciences (PNAS) Journal for their paper, “Using heparan sulfate octadecasaccharide (18-mer) as a multi-target agent to protect against sepsis”. Click here to read the paper.

January 26, 2023
Stephanie Reitsma’s proposal titled “Phenotypic modifiers in people with low factor XI” was awarded the American Heart Association (AHA) postdoctoral fellowship award. She will use a multidisciplinary approach to determine bleeding risk determinants in FXI deficiency. This project will be guided by her co-mentors Drs. Alisa Wolberg and Karin Leiderman for the duration of 2 …

January 26, 2023
Yaqiu Sang was awarded the Postdoctoral Fellowship from American Heart Association (Duration: 2023/1/1-2024/12/31) last December. The title of her awarded project is “Platelet factor XIII regulation and role in pulmonary embolism”. Under the guidance of Dr. Wolberg and Dr. Bergmeier, she will identify the mechanisms regulating platelet FXIII biology and the relative contributions of plasma …

January 26, 2023
Abigail Ballard, a BCBP PhD candidate in Wolfgang Bergmeier’s lab, was awarded a Ruth L. Kirschstein NRSA Predoctoral Fellowship (F31) from the National Heart, Lung, and Blood Institute. The proposal titled “The Role of the Small GTPase Rap1 in Platelet Coagulation Interplay” will investigate the regulation platelet procoagulant response by Rap1 and Rho family small …

January 23, 2023
Matthew S. Karafin, MD Msc Published in Transfusion, “Hypoxic storage of donor red cells preserves deformability after exposure to plasma from adults with sickle cell disease” Dr. Matthew Karafin was the lead author on a multi-institutional investigation into the role of red cell storage conditions and patient clinical state on donor red cell deformability. The …

January 23, 2023
Dr. Yohei Hisada was appointed as a Co-chair of the International Society on Thrombosis and Haemostasis (ISTH) Scientific and Standardization committee (SSC) on Vascular Biology. He will serve as a co-chair for 4 years. The detail about the ISTH SSC on Vascular Biology can be found here.

December 21, 2022
Brandi Reeves, MD was awarded a Core Facilities voucher to characterize neurobehavioral changes in a mouse model of polycythemia vera. Neurobehavioral complaints are common in patients with polycythemia vera (PV), with 75% of patients reporting symptoms. Fatigue, inactivity, and concentration difficulties are the most common and severe symptoms experienced by PV patients and result in …